Study guide
3.3 Controlled Substance Scheduling, Refill Restrictions, and C-II Exact Counts
PTCB Technician Product Verification TPV
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Tech-Check-Tech Verification Fundamentals
1.1 About the PTCB TPV Certificate Exam 1.2 Tech-Check-Tech (TCT) Scope, Regulations, and Quality Assurance 1.3 Systematic Verification Protocol & Visual Inspection Steps
2 Chapter 2: Drug Name Verification & Brand/Generic Identification
2.1 Brand vs Generic Mapping, USAN Stems, and Orange Book Therapeutic Equivalence 2.2 Salt Forms and Active Ingredient Verification 2.3 Manufacturer-Specific Identification, Visual Cues, and Color Codes
3 Chapter 3: Auxiliary Labels, REMS & Controlled Substances
3.1 Auxiliary Warning Labels and Mandatory Patient Counseling Triggers 3.2 REMS Programs and Restricted Distribution Medications 3.3 Controlled Substance Scheduling, Refill Restrictions, and C-II Exact Counts
4 Chapter 4: Dosage Forms, Release Mechanisms & Administration Routes
4.1 Modified-Release Formulations (ER, XL, SR, DR, CR) and "Do Not Crush" Rules 4.2 Route of Administration Verification: Ophthalmic vs Otic, Oral vs Topical vs Transdermal 4.3 Specialized Delivery Systems: Inhalers (MDI/DPI), ODTs, Solutions vs Suspensions
5 Chapter 5: Strength Verification & Pharmaceutical Calculations
5.1 Unit Conversions (mcg, mg, g) and Preventing Leading/Trailing Zero Errors 5.2 Percentage Strengths, Ratio Strengths, and Liquid Concentrations (mg/mL) 5.3 Electrolyte Equivalents (mEq vs mg) and Combination Product Strength Verification
6 Chapter 6: High-Alert Medications & Safety Protocols
6.1 ISMP High-Alert Medications and Independent Double-Check Protocols 6.2 Insulin Formulations, Concentrations (U-100, U-500, U-200, U-300), and Pen/Vial Math 6.3 Concentrated Electrolytes, Opioids, Neuromuscular Blockers, and Oral Methotrexate
7 Chapter 7: Look-Alike / Sound-Alike (LASA) Medications
7.1 FDA and ISMP Tall-Man Lettering Principles 7.2 High-Risk Community/Ambulatory LASA Pairs 7.3 High-Risk Institutional/Hospital LASA Pairs & Packaging Traps
8 Chapter 8: Packaging, Expiration, Storage & Special Handling
8.1 Expiration Date Interpretation and Multi-Dose Vial Beyond-Use Dating (BUD) 8.2 Packaging Integrity, Moisture/Light Sensitivity, and FDA Recall Classes 8.3 Temperature Storage Ranges and Vaccine Cold Chain Integrity 8.4 USP <800> Hazardous Drug Identification and Handling Precautions
9 Chapter 9: NDC Conversion, Repackaging & Final Dispensing Checks
9.1 NDC 10-Digit to 11-Digit Conversion (5-4-2 Standardization) 9.2 Unit-Dose Repackaging Standards and USP <795> BUD Guidelines 9.3 Days Supply Calculations, Package Size Verification, and Final Label Matching
3.3 Controlled Substance Scheduling, Refill Restrictions, and C-II Exact Counts
Key Takeaways Explain This Topic AI
The Controlled Substances Act (CSA) classifies regulated drugs into Schedules I through V based on accepted medical use, abuse liability, and psychological or physical dependence potential.
Schedule II (C-II) controlled substances (e.g., oxycodone, hydrocodone combos, morphine, methylphenidate) are strictly prohibited from having refills under federal law, and sequential prescriptions are limited to a maximum 90-day supply with 'Do Not Dispense Before' instructions.
Schedules III and IV medications permit a maximum of 5 refills within 6 months from the date of issue, whereas Schedule V medications may be refilled in accordance with prescriber authorization or state law.
All oral solid C-II medications require an exact physical double-count, initialing of the dispensing record by the verifying technician, and immediate entry into the perpetual inventory log to reconcile actual on-hand stock.
Controlled substance container labels must display the federal Schedule symbol (e.g., C-II, C-III, C-IV, C-V) and the mandatory Federal Transfer Warning statement prohibiting transfer to anyone other than the intended patient.
Last updated: August 2026
Controlled Substance Scheduling, Refill Restrictions, and C-II Exact Counts
The Controlled Substances Act (CSA) , Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, establishes the federal legal framework for regulating drugs and chemical substances with potential for abuse, physical dependence, or psychological dependence. The Drug Enforcement Administration (DEA), operating within the U.S. Department of Justice, enforces these statutes.
For pharmacy technicians authorized to perform technician product verification (TPV), controlled substance verification requires uncompromising vigilance. Verifying technicians must confirm proper DEA scheduling classification, adherence to federal and state refill restrictions, required label warning statements, exact double-count verification for Schedule II solids, and real-time perpetual inventory log reconciliation .
1. Federal Controlled Substance Schedules (Schedules I–V)
Controlled substances are divided into five distinct schedules based on their therapeutic utility, potential for abuse, and safety profile: +---------------------------------------------------------------------------------------------------+
- | DEA CONTROLLED SUBSTANCE SCHEDULES |
- +---------------------------------------------------------------------------------------------------+
- | SCHEDULE I (C-I) |
- | * Abuse Potential: High. |
- | * Medical Use: NO currently accepted medical use in the United States; lack of accepted safety. |
- | * Examples: Heroin, Lysergic acid diethylamide (LSD), Mescaline, Peyote, Methaqualone, |
- | 3,4-Methylenedioxymethamphetamine (MDMA / Ecstasy), unapproved synthetic cannabinoids. |
- | * Dispensing: Prohibited from being prescribed, dispensed, or verified in routine pharmacy. |
- +---------------------------------------------------------------------------------------------------+
- | SCHEDULE II (C-II) |
- | * Abuse Potential: High. |
- | * Dependence: Severe psychological or severe physical dependence. |
- | * Medical Use: Accepted medical use in the United States (with severe restrictions). |
- | * Opioids: Morphine, Oxycodone (OxyContin, Roxicodone, Percocet), Hydrocodone combination |
- | products (Norco, Vicodin, Lortab), Hydromorphone (Dilaudid), Fentanyl (Duragesic, Actiq), |
- | Oxymorphone (Opana), Methadone (Dolophine), Meperidine (Demerol), Codeine (single-entity). |
- | * Stimulants: Methylphenidate (Ritalin, Concerta), Dexmethylphenidate (Focalin), Amphetamine/ |
- | Dextroamphetamine (Adderall), Lisdexamfetamine (Vyvanse), Methamphetamine (Desoxyn). |
- | * Barbiturates / Others: Secobarbital (Seconal), Pentobarbital, Cocaine (topical solution). |
- | * REFILLS: ZERO (0) REFILLS PERMITTED BY FEDERAL LAW. |
- +---------------------------------------------------------------------------------------------------+
- | SCHEDULE III (C-III) |
- | * Abuse Potential: Less than Schedule I and II. |
- | * Dependence: Moderate or low physical dependence or high psychological dependence. |
- | * Examples: Buprenorphine and Buprenorphine/Naloxone (Suboxone, Subutex), Ketamine (Ketalar), |
- | Dronabinol (Marinol capsules), Anabolic Steroids (Testosterone, Oxandrolone), Acetaminophen |
- | with Codeine (Tylenol #3, Tylenol #4 -- containing <= 90 mg codeine per dosage unit), |
- | Butalbital/Aspirin/Caffeine (Fiorinal). |
- | * REFILLS: Maximum 5 refills within 6 months from the date of issue. |
- +---------------------------------------------------------------------------------------------------+
- | SCHEDULE IV (C-IV) |
- | * Abuse Potential: Low relative to Schedule III. |
- | * Dependence: Limited physical dependence or psychological dependence relative to C-III. |
- | * Benzodiazepines: Alprazolam (Xanax), Lorazepam (Ativan), Clonazepam (Klonopin), Diazepam |
- | (Valium), Temazepam (Restoril), Triazolam (Halcion), Midazolam (Versed). |
- | * Sedative-Hypnotics (Z-Drugs): Zolpidem (Ambien), Eszopiclone (Lunesta), Zaleplon (Sonata). |
- | * Other Agents: Tramadol (Ultram), Carisoprodol (Soma), Modafinil (Provigil), Phenobarbital. |
- | * REFILLS: Maximum 5 refills within 6 months from the date of issue. |
- +---------------------------------------------------------------------------------------------------+
- | SCHEDULE V (C-V) |
- | * Abuse Potential: Low relative to Schedule IV. |
- | * Composition: Preparations containing limited quantities of certain narcotics for cough/diarrhea|
- | * Examples: Pregabalin (Lyrica), Lacosamide (Vimpat), Diphenoxylate/Atropine (Lomotil), |
- | Antitussive syrups with codeine (Promethazine with Codeine, Robitussin AC -- containing |
- | <= 200 mg codeine per 100 mL or 100 g). |
- | * REFILLS: Refillable as authorized by prescriber (valid up to 1 year or state-defined rules). |
- +---------------------------------------------------------------------------------------------------+
- 2. Refill Rules, Validity Windows, and Special C-II Prescribing Regulations
- Regulatory Parameter Schedule II (C-II) Schedule III (C-III) Schedule IV (C-IV) Schedule V (C-V)
- Authorized Refills 0 (Zero) Up to 5 refills Up to 5 refills As authorized by prescriber
Prescription Expiration Federal: No expiration date*; (State laws typically set 30 to 90 days) 6 Months from date of issue 6 Months from date of issue 12 Months from date of issue (or state limit)
Emergency Verbal Order Allowed in immediate emergency; written/electronic cover Rx required within 7 days Allowed; must be reduced to writing Allowed; must be reduced to writing Allowed; must be reduced to writing
Multiple Sequential Prescriptions Prescriber may write up to 3 sequential prescriptions on the same day for up to a total 90-day supply , indicating "Do Not Dispense Before [Date]" Standard refill rules apply Standard refill rules apply Standard refill rules apply
Partial Fills (CARA Act 2016) Allowed; remaining portion must be filled within 30 days of original written date (or within 72 hours if pharmacy out-of-stock; within 60 days for LTCF/terminally ill) Allowed; total quantity dispensed cannot exceed total prescribed; valid up to 6 months Allowed; total quantity dispensed cannot exceed total prescribed; valid up to 6 months Allowed up to total authorized quantity; valid up to 12 months
3. Federal vs. Stricter State Scheduling Variations
A cornerstone principle in pharmaceutical law is that when federal and state laws conflict or differ, the pharmacy professional must ALWAYS comply with the MORE STRINGENT (stricter) regulation .
Notable State Variations in Controlled Substance Scheduling:
Gabapentin (Neurontin) :
Federal Law : Non-controlled legend drug.
State Law : Classified as a Schedule V controlled substance in numerous states (including Kentucky, Ohio, Tennessee, Virginia, West Virginia, Michigan, North Dakota, Alabama) due to widespread synergistic misuse and respiratory depression when combined with opioids.
Pseudoephedrine and Ephedrine :
Federal Law : Regulated under the Combat Methamphetamine Epidemic Act (CMEA) of 2005 as a Scheduled Listed Chemical Product (SLCP) with daily (3.6 g) and 30-day (9.0 g) purchase limits.
State Law : Classified as a Schedule III controlled substance or prescription-only medication in certain jurisdictions.
Schedule V Refill Restrictions :
Federal Law : Permits refills up to 1 year as authorized by prescriber.
State Law : Many states restrict Schedule V refills to a maximum of 5 refills within 6 months , identical to Schedules III and IV.
4. Prescription Labeling Requirements for Controlled Substances
When verifying a finished prescription label for a controlled substance, the technician must inspect and confirm two critical federal requirements:
A. DEA Schedule Symbol
The prescription label must clearly display the symbol designating the schedule of the controlled substance (e.g., C-II, C-III, C-IV, C-V or a prominent "C" enclosing the roman numeral II, III, IV, V ).
B. Federal Transfer Warning Caution Statement
Under federal regulation (21 CFR § 290.5), the label of any Schedule II, Schedule III, or Schedule IV controlled substance must carry the exact statutory statement:
"CAUTION: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed."
(Note: While federal statute specifically mandates this wording on Schedules II, III, and IV, pharmacy computer systems commonly print it on Schedule V labels as well for universal compliance).
5. Schedule II Exact Double-Count & Perpetual Inventory Protocols
Because of the extreme potential for diversion, abuse, and severe dependence associated with Schedule II substances, strict procedural safeguards govern their physical dispensing and inventory accounting. +---------------------------------------------------------------------------------------------------+
- | SCHEDULE II (C-II) EXACT DOUBLE-COUNT PROTOCOL |
- +---------------------------------------------------------------------------------------------------+
- | STEP 1: INITIAL PHYSICAL COUNT |
- | * Retrieve the stock container from the secure C-II safe or locked cabinet. |
- | * Clean the dedicated counting tray and spatula with 70% isopropanol (prevent cross-contamination). |
- | * Count the exact number of oral solid dosage units (tablets/capsules). NEVER estimate or guess.|
- | |
- | STEP 2: INDEPENDENT RE-COUNT (THE DOUBLE-COUNT) |
- | * Count the dosage units a SECOND TIME, verifying the exact count as tablets are transferred |
- | into the amber prescription dispensing vial. |
- | |
- | STEP 3: WRITTEN INITIALING / CERTIFICATION |
- | * The technician or dispensing personnel MUST initial and circle the written quantity on the |
- | physical prescription hard copy or computer verification label (e.g., "30 / [Initials]"). |
- | * Indicates formal legal certification that an exact double-count was physically performed. |
- | |
- | STEP 4: PERPETUAL INVENTORY LOG RECONCILIATION |
- | * Immediately log the transaction in the pharmacy's C-II Perpetual Inventory Record. |
- | * Record: Date, Rx Number, Patient Name, Quantity Dispensed, Remaining Physical Balance. |
- | * FORMULA: [ Starting Physical Balance ] - [ Quantity Dispensed ] = [ New Perpetual Balance ] |
- | * The on-hand physical stock remaining in the bottle/safe MUST EXACTLY MATCH the log balance. |
- +---------------------------------------------------------------------------------------------------+
Handling Schedule II Discrepancies and DEA Form 106:
Immediate Action : If the physical count of remaining stock does not match the perpetual inventory balance, the technician must STOP dispensing immediately and conduct an exhaustive search (checking recent dispensing records, returned stock, will-call bins, and waste logs).
Escalation : All unresolved discrepancies must be reported immediately to the Pharmacist-in-Charge (PIC) . Technicians are never permitted to alter or adjust perpetual inventory balance figures independently.
Mandatory DEA Reporting (DEA Form 106) :
Under federal law, the pharmacy must notify the DEA Field Division Office in writing of any significant theft or loss of controlled substances within ONE (1) BUSINESS DAY of discovery .
A formal DEA Form 106 (Report of Theft or Loss of Controlled Substances) must be submitted electronically through the DEA secure portal, alongside required notifications to state boards of pharmacy and local law enforcement.